Home/Filings/4/0001209191-22-010397
4//SEC Filing

Leland Shawn 4

Accession 0001209191-22-010397

CIK 0001783032other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 8:08 PM ET

Size

5.7 KB

Accession

0001209191-22-010397

Insider Transaction Report

Form 4
Period: 2022-02-14
Leland Shawn
DirectorPresident, CEO
Transactions
  • Award

    Employee Stock Option (Right to Buy)

    2022-02-14+186,500186,500 total
    Exercise: $3.78Exp: 2032-02-13Common Stock (186,500 underlying)
Footnotes (1)
  • [F1]The stock option vests as to 25% of the total shares on February 10, 2023, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date and is subject to acceleration in the event of a change in control of the Issuer.

Issuer

Elevation Oncology, Inc.

CIK 0001783032

Entity typeother

Related Parties

1
  • filerCIK 0001866173

Filing Metadata

Form type
4
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 8:08 PM ET
Size
5.7 KB